Next Event

@Hôtel Aquatis, Biopôle (Lausanne), May 19th

 

Oncology; innovation and excellence in the Health Valley

Program

While cancer is a long recognized disease, oncology can be perceived as a relatively modern specialty.  In the more recent years, the oncology landscape has dramatically evolved thanks to major development in some key fields such as personalized medicine and genomics, innovative treatments like immunotherapy, vaccines, or also highly performant diagnostics procedures.

 

However, cancer is still responsible for 8.2 million deaths per year worldwide, with 14.1 million new cases every year and  figures among the leading causes of morbidity and mortality worldwide. So, what are the latest trends in oncolgy, in which direction this very hot field is moving, what is driving innovation in the field and how does our region compare with other areas in the world in this particular arena?

 

These are some of the questions which will be addressed by experts, on the occasion of the next C-Suite to be held at Biopôle in Lausanne (Aquatis), on May 19th 2016. This new C-Suite conference will be the occasion for participants to listen to renown experts, namely Prof. George Coukos, who will shade light on those questions and share their perspectives on the evolution, and revolution, in oncology from the past and towards a promising future.

 

As usual, this C-Suite will be a mixture of short talks, lively roundtable and networking opportunities dedicated to a selective CXOs audience.

 

Program:

 

Introduction :

17h00-17h30 : Welcome and registrations

17h30 : Welcome word by Thierry Weber, MD, President of the Vaud BioMed Association

 

Conferences:

17h35-17h50 :  „New Developments in Oncology in Lausanne“, Prof. George Coukos,

17h55-18h10 : “Cell penetrating peptides and TLR peptide agonist: the Swiss army knife of cancer vaccines”, Dr. Madiha Derouazi (CEO) Amal therapeutics

 

18h15-18h30 : “Addressing an unmet medical need for patients with BCR-ABL driven Leukemias in Europe”, Dr. Nils Eckardt (Head of Medical Affairs), Ariad pharmaceuticals

18h35-18h50 : “Perspectives of the oncology market”, Mr Iain Scott, Lead analyst - Global Life Sciences, Ernst & Young AG

 

Round table :

Moderation : Dr. Ksenia Tugay, Inartis Foundation

18h55-19h30 : round table discussion and Q&As

 

19h30 : End of conference and beginning of networking session & cocktail.

 

FOOTER NAVIGATION

REGISTER TODAY